SRRK - Scholar Rock Holding

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Scholar Rock GAAP EPS of -$0.53 in-line
• Jefferies upgrades Scholar Rock to buy; cites SMA, obesity drug assets
• Scholar Rock Holding says Invus Public Equities buys 2.2M shares
• Scholar Rock prices upsized $85M offering
• Scholar Rock plans for $75M stock offering
• Scholar Rock gains as Phase 3 trial for SMA drug hits milestone
• Scholar Rock GAAP EPS of -$0.47 beats by $0.09
• FibroGen drives Scholar Rock, Omega lower after setback for lung disease candidate
• Scholar Rock extends slide amid concerns over Sarepta gene therapy approval
• Scholar Rock GAAP EPS of -$0.49
• Scholar Rock GAAP EPS of -$2.26 beats by $0.02, revenue of $33.19M in-line
• Scholar Rock appoints chief commercial officer
• Scholar Rock GAAP EPS of -$0.55 beats by $0.14
• Jay Backstrom is the new CEO at Scholar Rock
• Scholar Rock GAAP EPS of -$1.06 misses by $0.02
• Scholar Rock initiated at buy at Truist on platform for rare diseases and oncology
• Biopharma Scholar Rock gives up most of Monday's 23% gain
• Scholar Rock rallies 27% most since 2020 after insider purchase
• GH, FUV and CBAY among after hour movers.
• Scholar Rock to raise $205M in stock and pre-funded warrant offering